Characteristics of patients dismissed from a retina practice.
| Title: | Characteristics of patients dismissed from a retina practice. |
|---|---|
| Authors: | Adams OE; Wills Eye Hospital Retina Service, Mid Atlantic Retina, Philadelphia, PA, USA.; Ni R; Wills Eye Hospital Retina Service, Mid Atlantic Retina, Philadelphia, PA, USA.; Momenaei B; Wills Eye Hospital Retina Service, Mid Atlantic Retina, Philadelphia, PA, USA.; Nguyen MK; Wills Eye Hospital Retina Service, Mid Atlantic Retina, Philadelphia, PA, USA.; Pulido JS; Wills Eye Hospital Retina Service, Mid Atlantic Retina, Philadelphia, PA, USA.; Hsu J; Wills Eye Hospital Retina Service, Mid Atlantic Retina, Philadelphia, PA, USA. jhsu@midatlanticretina.com. |
| Source: | Eye (London, England) [Eye (Lond)] 2026 May; Vol. 40 (7), pp. 986-992. Date of Electronic Publication: 2026 Feb 25. |
| Publication Type: | Journal Article |
| Language: | English |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8703986 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5454 (Electronic) Linking ISSN: 0950222X NLM ISO Abbreviation: Eye (Lond) Subsets: MEDLINE |
| Imprint Name(s): | Publication: : London : Nature Publishing Group; Original Publication: [London : Ophthalmological Society of the United Kingdom, 1987- |
| MeSH Terms: | Ophthalmology*/statistics & numerical data ; Patient Compliance*/statistics & numerical data ; Retinal Diseases*/therapy; Private Practice/statistics & numerical data ; Humans ; Retrospective Studies ; Male ; Female ; Middle Aged ; Aged ; Adult ; Aged, 80 and over ; Socioeconomic Factors ; Young Adult |
| Abstract: | Background/objective: To evaluate the demographic, clinical, and behavioural characteristics associated with patient dismissals in a retina-only private practice.; Subjects/methods: A Retrospective cohort study was conducted of all patients seen at a single-specialty retina practice over a seven-year period (N = 174,250), including 432 patients who were formally dismissed. Dismissed patients were compared to retained patients across demographic, clinical, and behavioural characteristics. Data on reasons for dismissal, diagnoses, and treatment history were collected and analysed.; Results: Among 174,250 patients seen during the study period, 432 (0.25%) were dismissed. The most common reasons included noncompliance with medical recommendations (n = 260, 60.2%) and aggressive or inappropriate behaviour (n = 79, 18.2%). Compared to retained patients, dismissed patients were younger (mean of 55.9 vs. 66.3 years, p |
| Competing Interests: | Competing interests: The authors declare no competing interests. |
| References: | Weiss M, Sim DA, Herold T, Schumann RG, Liegl R, Kern C, et al. Compliance and adherence of patients with diabetic macular edema to intravitreal anti-vascular endothelial growth factor therapy in daily practice. Retina. 2018;38:2293–300. https://doi.org/10.1097/IAE.0000000000001892 . (PMID: 10.1097/IAE.000000000000189229068914); Giocanti-Aurégan A, García-Layana A, Peto T, Gentile B, Chi GC, Mirt M, et al. Drivers of and barriers to adherence to neovascular age-related macular degeneration and diabetic macular edema treatment management plans: a multi-national qualitative study. Patient Prefer Adherence. 2022;16:587–604. https://doi.org/10.2147/PPA.S347713 . (PMID: 10.2147/PPA.S347713352648478901255); Adams OE, Schechet SA, Hariprasad SM. Discontinuous to continuous therapy for persistent diabetic macular edema leads to reduction in treatment frequency. Eur J Ophthalmol. 2021;31:612–9. https://doi.org/10.1177/1120672120901691 . (PMID: 10.1177/112067212090169131964171); Teo KYC, Nguyen V, O’Toole L, Daien V, Sanchez-Monroy J, Ricci F, et al. Longer treatment intervals are associated with reduced treatment persistence in neovascular age related macular degeneration. Eye (Lond). 2023;37:467–73. https://doi.org/10.1038/s41433-022-01957-z . (PMID: 10.1038/s41433-022-01957-z35140329); Campochiaro PA, Sophie R, Pearlman J, Brown DM, Boyer DS, Heier JS, et al. Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN study. Ophthalmology. 2014;121:209–19. https://doi.org/10.1016/j.ophtha.2013.08.038 . (PMID: 10.1016/j.ophtha.2013.08.03824112944); Obeid A, Gao X, Ali FS, Talcott KE, Aderman CM, Hyman L, et al. Loss to follow-up in patients with proliferative diabetic retinopathy after panretinal photocoagulation or intravitreal anti-VEGF injections. Ophthalmology. 2018;125:1386–92. https://doi.org/10.1016/j.ophtha.2018.02.034 . (PMID: 10.1016/j.ophtha.2018.02.03429606377); Rush RB, Rush SW. Outcomes in patients resuming intravitreal anti-vascular endothelial growth factor therapy following treatment delay during the coronavirus-19 pandemic. Retina. 2021;41:2456–61. https://doi.org/10.1097/IAE.0000000000003276 . (PMID: 10.1097/IAE.000000000000327634369441); O’Malley AS, Swankoski K, Peikes D, Crosson J, Duda N, Day T, et al. Patient dismissal by primary care practices. JAMA Intern Med. 2017;177:1048–50. https://doi.org/10.1001/jamainternmed.2017.1309 . (PMID: 10.1001/jamainternmed.2017.1309285052155818806); Groisser AR, Reyes Nieva H, Ruan E, Wright A, Schiff GD. Terminations in primary care: a retrospective observational study of 16 primary care clinics. J Gen Intern Med. 2022;37:548–55. https://doi.org/10.1007/s11606-021-06793-7 . (PMID: 10.1007/s11606-021-06793-733948801); Farber NJ, Jordan ME, Silverstein J, Collier VU, Weiner J, Boyer EG. Primary care physicians’ decisions about discharging patients from their practices. J Gen Intern Med. 2008;23:283–7. https://doi.org/10.1007/s11606-007-0495-7 . (PMID: 10.1007/s11606-007-0495-7181768522359473); Cummings R, Young S. Patient removals. Sitting pretty. Health Serv J. 2000;110:26–27. (PMID: 11183326); Pickin M, Sampson F, Munro J, Nicholl J. General practitioners’ reasons for removing patients from their lists: postal survey in England and Wales. BMJ. 2001;322:1158–9. https://doi.org/10.1136/bmj.322.7295.1158 . (PMID: 10.1136/bmj.322.7295.11581134891131594); Sampson F, Munro J, Pickin M, Nicholl J. Why are patients removed from their doctors’ lists? A comparison of patients’ and doctors’ accounts of removal. Fam Pr. 2004;21:515–8. https://doi.org/10.1093/fampra/cmh507 . (PMID: 10.1093/fampra/cmh507); Stokes T, Dixon-Woods M, McKinley RK. Breaking up is never easy: GPs’ accounts of removing patients from their lists. Fam Pr. 2003;20:628–34. https://doi.org/10.1093/fampra/cmg602 . (PMID: 10.1093/fampra/cmg602); Rosenthal LJ, Byerly A, Taylor AD, Martinovich Z. Impact and prevalence of physical and verbal violence toward healthcare workers. Psychosomatics. 2018;59:584–90. https://doi.org/10.1016/j.psym.2018.04.007 . (PMID: 10.1016/j.psym.2018.04.00729909013); Jacobsen C, Volkmann I, Wedegärtner F, Harris J, Bertram B, Gass P, et al. Erfahrungen von Aggression und Gewalt gegen Augenärztinnen und Augenärzte [Experiences of aggression and violence against ophthalmologists]. Ophthalmologe. 2020;117:775–85. https://doi.org/10.1007/s00347-020-01039-z . (PMID: 10.1007/s00347-020-01039-z32025792); Antoine C, Luc MS, Gross G, Schwitzer T, Hettal L, Conart J-B, et al. Agressivité et violence au cours de l’exercice professionnel en ophtalmologie : analyse descriptive d’un questionnaire adressé aux internes et assistants des régions Grand Est, Bourgogne-Franche-Comté [Aggressiveness and violence in daily ophthalmology practice: Descriptive analysis of a survey sent to residents and assistants in Grand Est and Bourgogne-Franche-Comté]. J Fr Ophtalmol. 2024;47:103994. https://doi.org/10.1016/j.jfo.2023.07.015 . (PMID: 10.1016/j.jfo.2023.07.01537903682); Butler DC, Petterson S, Phillips RL, Bazemore AW. Measures of social deprivation that predict health care access and need within a rational area of primary care service delivery. Health Serv Res. 2013;48:539–59. https://doi.org/10.1111/j.1475-6773.2012.01449.x . (PMID: 10.1111/j.1475-6773.2012.01449.x22816561); Social deprivation index (SDI). Robert Graham Center - Policy Studies in Family Medicine & Primary Care. (2018, November 5). Retrieved April 10, 2025, from https://www.graham-center.org/maps-data-tools/social-deprivation-index.html .; Cottrell EK, Hendricks M, Dambrun K, Cowburn S, Pantell M, Gold R, et al. Comparison of community-level and patient-level social risk data in a network of community health centers. JAMA Netw Open. 2020;3:e2016852. https://doi.org/10.1001/jamanetworkopen.2020.16852 . (PMID: 10.1001/jamanetworkopen.2020.16852331191027596576); Schulze-Bonsel K, Feltgen N, Burau H, Hansen L, Bach M. Visual acuities “hand motion” and “counting fingers” can be quantified with the freiburg visual acuity test. Invest Ophthalmol Vis Sci. 2006;47:1236–40. https://doi.org/10.1167/iovs.05-0981 . (PMID: 10.1167/iovs.05-098116505064); Fiscella K, Williams DR. Health disparities based on socioeconomic inequities: implications for urban health care. Acad Med. 2004;79:1139–47. https://doi.org/10.1097/00001888-200412000-00004 . (PMID: 10.1097/00001888-200412000-0000415563647); Pérez-Stable EJ, Webb Hooper M. The Pillars of Health Disparities Science-Race, Ethnicity, and Socioeconomic Status. JAMA Health Forum. 2023;4:e234463. https://doi.org/10.1001/jamahealthforum.2023.4463 . (PMID: 10.1001/jamahealthforum.2023.446338127587); Photocoagulation for diabetic macular edema. Early treatment diabetic retinopathy study report number 1. early treatment diabetic retinopathy study research group. Arch Ophthalmol. 1985;103:1796–806. (PMID: 10.1001/archopht.1985.01050120030015); Schachat AP. If there is loss to follow up, poor outcomes may be more common after anti-vascular endothelial growth factor treatment for diabetic retinopathy. Ophthalmology. 2019;126:414. https://doi.org/10.1016/j.ophtha.2018.09.024 . (PMID: 10.1016/j.ophtha.2018.09.02430803515); Green M, Tien T, Ness S. Predictors of lost to follow-up in patients being treated for proliferative diabetic retinopathy. Am J Ophthalmol. 2020;216:18–27. https://doi.org/10.1016/j.ajo.2020.03.023 . (PMID: 10.1016/j.ajo.2020.03.02332243878); Obeid A, Su D, Patel SN, Uhr JH, Borkar D, Gao X, et al. Outcomes of eyes lost to follow-up with proliferative diabetic retinopathy that received panretinal photocoagulation versus intravitreal anti-vascular endothelial growth factor. Ophthalmology. 2019;126:407–13. https://doi.org/10.1016/j.ophtha.2018.07.027 . (PMID: 10.1016/j.ophtha.2018.07.02730077614) |
| Entry Date(s): | Date Created: 20260225 Date Completed: 20260511 Latest Revision: 20260514 |
| Update Code: | 20260514 |
| PubMed Central ID: | PMC13161359 |
| DOI: | 10.1038/s41433-026-04332-4 |
| PMID: | 41741694 |
| Database: | MEDLINE |
Journal Article